The Company (Details Narrative) - USD ($)				3 Months Ended				6 Months Ended
	Aug. 02, 2024	Dec. 14, 2023	Jun. 05, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit				$ 82,558,661				$ 82,558,661		$ 80,908,958
Operating expenses								5,100,000
Net loss				783,733	$ 865,970	$ 1,769,238	$ 3,709,899	1,649,703	$ 5,479,137
Net cash used in operating activities								2,199,276	4,982,666
Cash				$ 2,332,068				2,332,068		$ 3,026,569
Proceeds from warrant exercises	$ 1,700,000							$ 436
Stockholders' equity, reverse stock split		the Company filed an amendment to its amended and restated certificate of incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-8 reverse stock split of its outstanding common stock and warrants	the Company filed an amendment to its amended and restated certificate of incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-30 reverse stock split of its outstanding common stock and warrants